表紙
市場調查報告書
商品編碼
1040438

生物銀行的全球市場(2021年∼2027年)

Biobanking Market 2021-2027

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球生物銀行的市場規模在預測期間內預計將以6.7%的年複合成長率增長。

市場成長的主要因素有需要解決日益增多的癌症和慢性疾病、增加研發投資、政府舉措以及提高對乾細胞療法的認識。另一方面,對自動化的高度關注和與生物資源樣本採購相關的問題是抑制市場增長的因素。。

本報告提供全球生物銀行市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品類型·樣品各類型·各應用領域·各地區的分析,競爭情形,再加上主要企業的簡介等全面性資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的見解與目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的開發
  • 主要策略分析
  • COVID-19對主要企業的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場明細

  • 全球生物銀行市場:各產品類型
    • 設備
    • 消耗品
    • 服務·軟體
  • 全球生物銀行市場:樣品各類型
    • 血液製劑
    • 人組織
    • 核酸
    • 細胞株
    • 生物液
    • 人糞尿產品
  • 全球生物銀行市場:各應用領域
    • 臨床研究
    • 再生醫療

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • AstraZeneca PLC
  • Becton, Dickinson and Co.
  • BioChain Institute Inc.
  • Biokryo GmbH
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Bristol-Myers Squibb Co.
  • Cell&Co.
  • Charles River Laboratories International, Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hamilton Co.
  • Lonza Group
  • LVL Technologies GmbH & Co. KG
  • Merck KGaA and Co.
  • Micronic Europe BV
  • Modul-Bio
  • Pfizer Inc.
  • PromoCell GmbH
  • QIAGEN GmbH
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
目錄
Product Code: OMR2023989

Global Biobanking Market Size, Share &Trends Analysis Report by Product Type (Equipment, Consumables, and Services &Software), By Sample Type (Blood Products, Human Tissues, Nucleic Acid, Cell Lines, Biological Fluid, and Human Waste Product), and by Applications (Clinical Research, and Regenerative Medicine) Forecast, 2021-2027

The biobanking market is anticipated to grow at a substantial CAGR of 6.7% during the forecast period. The market is set to display impressive growth during the forecast period with some key trends emerging, such as the need of tackling the increasing prevalence of cancers and chronic diseases driven by continuously evolving end-user expectations. The biobanking market is focused on the production and refurbishment of technologically advanced devices within time constraints by carrying out several types of research. It also depends on the level of inventory management practices of OEM and MRO clients. The growth in the R&D investments, government initiatives, and policies to reduce the prevalence of several diseases and the increase in awareness about stem cell therapies are some of the opportunities for the market players in the forecast period

Further, the high focus on automation and issues related to biospecimen sample procurement are the factors that are restraining the market growth during the forecast period. The global biobanking market suffered a growth in market share during the COVID-19 crisis as there was a huge rise in researches during Q1 and Q2 2020. The impact of SARS-COV-2 and COVID-19 on the global biobanking market is evolving to find new ways of controlling the global pandemic, other chronic diseases, and the rise in cancer patients

The global biobanking market is segmented based on product type, sample type, and segment. Based on product type segment, the market is segmented into equipment, consumables, and software and services. Among these, the equipment segment is expected to grow with the highest share due to the increase in the new biobanks among various geographies across the globe. Based on the sample type segment, the market is segmented into blood products, human tissues, nucleic acid, cell lines, biological fluid, and human waste products. Further, based on the application segment, the market is bifurcated into clinical research and regenerative medicine

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing market for biobanking. Innovative manufacturing, which was once a stronghold of the US and a few European economies such as France, Italy, and Germany, is set to expand to emerging economies, with next-generation largescale manufacturing centers to be planned predominantly in the Asia-Pacific region. The establishment of research centers in the Asian economies of Japan, South Korea, Taiwan, and China, which involve the highest degree of clinical researches, is set to increase the demand for biobanking in the forecast period

Further, Becton, Dickinson and Co., Thermo Fisher Scientific Inc., AstraZeneca plc, Charles River Laboratories, Inc., Boehringer Ingelheim Pharma GmbH &Co. KG, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd, among others are the key players in the market, To remain competitive in the market, the players are adopting different strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others. For instance, in February 2021, Charles River Laboratories, Inc. has announced the acquisition of Cognate BioServices, Inc., a leading cell and gene therapy contract development and manufacturing organization (CDMO), which has $875 million in cash, subject to customary closing adjustments

Research Methodology

The market study of the global biobanking market is incorporated by extensive primary and secondary research conducted by the research team at OMR Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market

Whitepapers, research papers, and news blogs

Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Biobanking Market Research and Analysis by Product Type

Global Biobanking Market Research and Analysis by Sample Type

Global Biobanking Market Research and Analysis by Application

The Report Covers

Comprehensive research methodology of the global biobanking market

This report also includes a detailed and extensive market overview with key analyst insights

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations

Analysis of regional regulations and other government policies impacting the global biobanking market

Insights about market determinants that are stimulating the global biobanking market

Detailed and extensive market segments with the regional distribution of forecasted revenues

Extensive profiles and recent developments of market players

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Bio-Banking Market
  • Recovery Scenario of Bio-Banking Market Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Bio-Banking Market by Product Type
    • 5.1.1. Equipment
    • 5.1.2. Consumables
    • 5.1.3. Services&Software
  • 5.2. Global Bio-banking Market by Sample Type
    • 5.2.1. Blood Products
    • 5.2.2. Human Tissues
    • 5.2.3. Nucleic Acid
    • 5.2.4. Cell Lines
    • 5.2.5. Biological Fluid
    • 5.2.6. Human Waste Product
  • 5.3. Global Bio-banking Market by Application
    • 5.3.1. Clinical Research
    • 5.3.2. Regenerative Medicine

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. AstraZeneca PLC
  • 7.3. Becton, Dickinson and Co.
  • 7.4. BioChain Institute Inc.
  • 7.5. Biokryo GmbH
  • 7.6. Boehringer Ingelheim Pharma GmbH & Co. KG
  • 7.7. Bristol-Myers Squibb Co.
  • 7.8. Cell&Co.
  • 7.9. Charles River Laboratories International, Inc.
  • 7.10. Danaher Corp.
  • 7.11. F. Hoffmann-La Roche Ltd.
  • 7.12. Hamilton Co.
  • 7.13. Lonza Group
  • 7.14. LVL Technologies GmbH & Co. KG
  • 7.15. Merck KGaA and Co.
  • 7.16. Micronic Europe BV
  • 7.17. Modul-Bio
  • 7.18. Pfizer Inc.
  • 7.19. PromoCell GmbH
  • 7.20. QIAGEN GmbH
  • 7.21. Tecan Trading AG
  • 7.22. Thermo Fisher Scientific Inc.
  • 7.23. Ziath Ltd.

LIST OF TABLES

1. GLOBAL BIOBANKING MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLIONS)

2. GLOBAL BIOBANKING MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLIONS)

3. GLOBAL BIOBANKING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLIONS)

4. GLOBAL EQUIPMENT FOR BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

5. GLOBAL CONSUMABLES FOR BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

6. GLOBAL SOFTWARE & SERVICES FOR BIOBANKINGMARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

7. GLOBAL BIOBANKING MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2020-2027 ($ MILLIONS)

8. GLOBAL BLOOD PRODUCTS IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

9. GLOBAL HUMAN TISSUES IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027, ($ MILLIONS)

10. GLOBAL NUCLEIC ACID IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027, ($ MILLIONS)

11. GLOBAL CELL LINES IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027, ($ MILLIONS)

12. GLOBAL BIOLOGICAL FLUID IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027, ($ MILLIONS)

13. GLOBAL HUMAN WASTE PRODUCT IN BIOBANKING MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

14. GLOBAL BIOBANKING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLIONS)

15. GLOBAL BIOBANKING IN CLINICAL RESEARCH MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

16. GLOBAL BIOBANKING IN REGENERATIVE MEDICINE MARKET RESEARCH AND ANALYSIS 2020-2027 ($ MILLIONS)

17. NORTH AMERICAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLIONS)

18. NORTH AMERICAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLIONS)

19. NORTH AMERICAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2020-2027 ($ MILLIONS)

20. NORTH AMERICAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLIONS)

21. EUROPEAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLIONS)

22. EUROPEAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLIONS)

23. EUROPEAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2020-2027 ($ MILLIONS)

24. EUROPEAN BIOBANKING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLIONS)

25. ASIA-PACIFIC BIOBANKING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLIONS)

26. ASIA-PACIFIC BIOBANKING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLIONS)

27. ASIA-PACIFIC BIOBANKING MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2020-2027 ($ MILLIONS)

28. ASIA-PACIFIC BIOBANKING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLIONS)

29. REST OF THE WORLD BIOBANKING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2020-2027 ($ MILLIONS)

30. REST OF THE WORLD BIOBANKING MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2020-2027 ($ MILLIONS)

31. REST OF THE WORLD BIOBANKING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLIONS)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL BIOBANKING MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL BIOBANKING MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL BIOBANKING MARKET, 2021-2027 (%)
  • 4. GLOBAL BIOBANKING MARKET SHARE, BY PRODUCT TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL BIOBANKING MARKET SHARE, BY SAMPLE TYPE,2020 VS 2027 (%)
  • 6. GLOBAL BIOBANKING MARKET SHARE, BY APPLICATION, 2020 VS 2027 (%)
  • 7. GLOBAL EQUIPMENT FOR BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 8. GLOBAL CONSUMABLES FOR BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 9. GLOBAL SOFTWARE AND SERVICES FOR BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 10. GLOBAL BLOOD PRODUCTS IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 11. GLOBAL HUMAN TISSUES IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 12. GLOBAL NUCLEIC ACID IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 13. GLOBAL CELL LINES IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 14. GLOBAL BIOLOGICAL FLUID IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 15. GLOBAL HUMAN WASTE PRODUCT IN BIOBANKING MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 16. GLOBAL BIOBANKING IN CLINICAL RESEARCH MARKET SHARE BY REGION, 2020 VS 2027(%)
  • 17. GLOBAL BIOBANKING IN REGENERATIVE MEDICINE MARKET SHARE BY REGION, 2020 VS 2027(%)

18. US BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

19. CANADA BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

20. UK BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

21. FRANCE BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

22. GERMANY BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

23. ITALY BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

24. SPAIN BIOBANKING MARKET SIZE, 2017 AND 2023, ($ MILLIONS)

25. ROE BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

26. INDIA BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

27. CHINA BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

28. JAPAN BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

29. SOUTH KOREA BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

30. ROAPAC BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)

31. REST OF THE WORLD BIOBANKING MARKET SIZE, 2020-2027 ($ MILLIONS)